NEW YORK (Reuters Health)—New European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria can be used to identify patients with systemic lupus erythematosus (SLE) in an unselected group of patients hospitalized for pericardial effusion, new findings show.1 “Overall, in patients with pericardial effusion and positive ANA, the diagnosis of SLE could be ruled out…
Articles by Natasha Yetman
Tears of Knee Ligaments & Meniscus Carry Highest Arthritis Risk
(Reuters Health)—Young adults who have had knee injuries are much more likely than uninjured peers to develop knee osteoarthritis (OA) by middle age, especially if they have broken bones or torn connective tissue, a recent study suggests. Cruciate ligament injuries were associated with a 19.6% greater risk of knee osteoarthritis, the study found. Meniscal tears…
Immunoassay May Help Identify Pediatric Lyme Arthritis
NEW YORK (Reuters Health)—In Lyme disease-endemic areas, a C6 peptide enzyme immunoassay (EIA) test may help guide initial management of children with acute arthritis, an observational study suggests.1 “Children with Lyme disease frequently present to the emergency department with an inflamed joint,” Lise Nigrovic, MD, MPH, of Boston Children’s Hospital tells Reuters Health by email….
U.S. Accuses CVS of Defrauding Medicare over Prescriptions
NEW YORK, Dec 17 (Reuters)—CVS Health Corp. and its Omnicare unit were sued on Tuesday by the U.S. government, which accused them of fraudulently billing Medicare and Medicaid for hundreds of thousands of drugs without valid prescriptions. The U.S. Department of Justice joined two whistleblower lawsuits accusing Omnicare of failing to obtain new prescriptions from…
Declining Numbers of Americans Have a Primary Care Provider
(Reuters Health)—In a little over a decade, the number of patients in the U.S. with primary care providers dropped by 2%, a new study finds. Between 2002 and 2015, fewer and fewer Americans of all ages, except for those in their 80s, had a primary care provider, researchers report in JAMA Internal Medicine.1 Although 2%…
Male Researchers Call Their Work ‘Novel’ More Often Than Women
(Reuters Health)—Male scientists are more likely than their female counterparts to use superlatives, such as first or novel, to describe their work, a new study suggests, and this disparity might contribute to other professional gender gaps, the authors say. The study team analyzed the language used in more than 6 million papers in peer-reviewed medical…
My Experience at the 2019 Rheumatology Research Workshop: Opportunity to Meet Peers & Role Models
I had the opportunity to attend the Rheumatology Research Workshop in Washington, D.C., in June 2019. Held annually, this two-day meeting is run by the ACR Early Career Investigators (ECI) Subcommittee and is geared toward trainees at all levels (fellows, residents and medical students) and junior faculty with an interest in a rheumatology research career….
FDA Approves Amgen’s Infliximab Biosimilar Treatment
(Reuters)—The U.S. Food and Drug Administration on Friday approved Amgen Inc.’s biosimilar copy of Johnson & Johnson’s blockbuster rheumatoid arthritis drug, Remicade (infliximab), according to the regulator’s website. The biosimilar, Avsola (infliximab-axxq), has the same chemical components, dosage form and strength as Remicade and would treat a range of autoimmune disorders. The label for the…
Trump Says He Will Allow States to Import Prescription Drugs to Lower Costs
WASHINGTON (Reuters)—U.S. President Donald Trump said on Friday, Nov. 22, he will soon release a plan to let Florida and other states import prescription medicines to combat high drug prices. He blasted the Democrat-led U.S. House of Representatives for not going far enough in a drug-pricing bill. “We will soon be putting more options on…
New Consensus Recommendations Guide Sjögren’s Syndrome Management
NEW YORK (Reuters Health)—New consensus-based recommendations from the European League Against Rheumatism (EULAR) address the management of Sjögren’s syndrome with topical and systemic therapies. Sjögren’s syndrome presents with a broad spectrum of clinical manifestations and autoantibodies, including antinuclear antibodies (the most frequently detected), anti-Ro/SS-A (the most specific) and cryoglobulins and hypocomplementemia (the main prognostic markers)….
- « Previous Page
- 1
- …
- 18
- 19
- 20
- 21
- 22
- …
- 97
- Next Page »